Lincoln Pharma. (LINCOLN)
FAST GROWERFairStock Score: 53/100 — MIXED
Score breakdown: P/E: 2/3 · ROCE: 1/2 · Growth: 2/2 · Dividend: 0/1
Key Financials
| Current Price | ₹611.45 |
| Market Cap | ₹1,263.98 Cr |
| P/E Ratio | 14.39 |
| ROCE | 17.28% |
| ROE | 13.74% |
| Dividend Yield | 0.29% |
| Profit Growth | 37.7% |
| Debt/Equity | 0 |
| Sales Growth | 13.49% |
| Promoter Holding | 49.78% |
| 52-Week Range | ₹440 — ₹770 |
| Sector | Pharmaceuticals & Biotechnology |
| Book Value | ₹322.75 |
Lincoln Pharma. trades with a P/E ratio of 14.39, ROCE of 17.28%, ROE of 13.74%, profit growth of 37.7%, debt-to-equity of 0. The FairStock Score of 53/100 suggests mixed fundamentals — some metrics look solid while others need improvement.
Data from BSE/NSE filings. AI analysis is for educational purposes only — not investment advice. Scoring methodology · Disclaimer